The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Global epidemiology of HTLV-I infection and associated diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7415 · Cited by 5,043 · cited 2×
“It has been convincingly associated with adult T-cell leukemia/lymphoma (ATL) (Poiesz et al., 1980; Hinuma et al., 1981; Miyoshi et al., 1981b; Yoshida et al., 1984; Takatsuki et al., 1985a, b), HAM/TSP (Cruikshank, 1956; Gessain et al., 1985; RodgersJohnson et al., 1985; Osame et al., 1986b;…”
BackgroundANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS
Gessain, A., Vernant, J. C., Maurs, L., Barin, F., Gout, O., Calender, A., & De Thé, G. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92734-5 · Cited by 2,843
HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY
Osame, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, M., & Tara, M. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91298-5 · Cited by 2,404
Adult T-cell leukemia: clinical and hematologic features of 16 cases
Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., & Uchino, H. (1977) · Blood · doi:10.1182/blood.v50.3.481.481 · Cited by 2,316
Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K. I., Shirakawa, S., & Miyoshi, I. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6476 · Cited by 2,252
Miyoshi, I., Kubonishi, I., Yoshimoto, S., Akagi, T., Ohtsuki, Y., Shiraishi, Y., Nagata, K., & Hinuma, Y. (1981) · Nature · doi:10.1038/294770a0 · Cited by 1,402
Yoshida, M., Seiki, M., Yamaguchi, K., & Takatsuki, K. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.8.2534 · Cited by 891 · cited 1×
“It has been convincingly associated with adult T-cell leukemia/lymphoma (ATL) (Poiesz et al., 1980; Hinuma et al., 1981; Miyoshi et al., 1981b; Yoshida et al., 1984; Takatsuki et al., 1985a, b), HAM/TSP (Cruikshank, 1956; Gessain et al., 1985; RodgersJohnson et al., 1985; Osame et al., 1986b;…”
Okochi, K., Sato, H., & Hinuma, Y. (1984) · Vox Sanguinis · doi:10.1111/j.1423-0410.1984.tb00083.x · Cited by 663
ADULT T-CELL LYMPHOMA-LEUKAEMIA IN BLACKS FROM THE WEST INDIES
Catovsky, D., Rose, M., Goolden, A. W. G., White, J. M., Bourikas, G., Brownell, A. I., Blattner, W. A., Greaves, M. F., Galton, D. A. G., Mccluskey, D. R., et al. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92200-0 · Cited by 522
Infective dermatitis of Jamaican children: a marker for HTLV-I infection
Blattner, W., LaGrenade, L., Hanchard, B., Fletcher, V., & Cranston, B. (1990) · The Lancet · doi:10.1016/0140-6736(90)92896-p · Cited by 453
Cited by
Epidemiological Aspects and World Distribution of HTLV-1 Infection
Gessain, A., & Cassar, O. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00388 · Cited by 1,428
Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation
Matsuoka, M., & Jeang, K.-T. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2111 · Cited by 829
Human T-lymphotropic virus 1: recent knowledge about an ancient infection
Verdonck, K., González, E., Van Dooren, S., Vandamme, A.-M., Vanham, G., & Gotuzzo, E. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70081-6 · Cited by 661
Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases
Gonçalves, D. U., Proietti, F. A., Ribas, J. G. R., Araújo, M. G., Pinheiro, S. R., Guedes, A. C., & Carneiro-Proietti, A. B. F. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00063-09 · Cited by 478
Self-citationCCR4 and its ligands: from bench to bedside
Yoshie, O., & Matsushima, K. (2015) · International Immunology · doi:10.1093/intimm/dxu079 · Cited by 427
Viruses associated with human cancer
McLaughlin-Drubin, M. E., & Munger, K. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.12.005 · Cited by 406
Abrahams, M.-R., Anderson, J. A., Giorgi, E. E., Seoighe, C., Mlisana, K., Ping, L.-H., Athreya, G. S., Treurnicht, F. K., Keele, B. F., Wood, N., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02132-08 · Cited by 381
Iwanaga, M., Watanabe, T., Utsunomiya, A., Okayama, A., Uchimaru, K., Koh, K.-R., Ogata, M., Kikuchi, H., Sagara, Y., Uozumi, K., et al. (2010) · Blood · doi:10.1182/blood-2009-12-257410 · Cited by 363
Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma
Ishitsuka, K., & Tamura, K. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70202-5 · Cited by 343
Gillet, N. A., Malani, N., Melamed, A., Gormley, N., Carter, R., Bentley, D., Berry, C., Bushman, F. D., Taylor, G. P., & Bangham, C. R. M. (2011) · Blood · doi:10.1182/blood-2010-10-312926 · Cited by 316
Matsuoka, M., & Jeang, K.-T. (2011) · Oncogene · doi:10.1038/onc.2010.537 · Cited by 268
Infections and cancer: Established associations and new hypotheses
de Martel, C., & Franceschi, S. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.07.021 · Cited by 258
Adult T-Cell Leukemia: A Review of Epidemiological Evidence
Iwanaga, M., Watanabe, T., & Yamaguchi, K. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00322 · Cited by 255
Global patterns and trends in the incidence of non-Hodgkin lymphoma
Miranda-Filho, A., Piñeros, M., Znaor, A., Marcos-Gragera, R., Steliarova-Foucher, E., & Bray, F. (2019) · Cancer Causes & Control · doi:10.1007/s10552-019-01155-5 · Cited by 158
Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis
Kannian, P., & Green, P. L. (2010) · Viruses · doi:10.3390/v2092037 · Cited by 139
“large granular lymphocytic leukemia (T-gamma lymphoproliferative disease) [60,61], dermatitis, lymphadenitis and Sjogren’s syndrome [62].”
BackgroundHTLV in the Americas: challenges and perspectives
Carneiro-Proietti, A. B. F., Catalan-Soares, B. C., Castro-Costa, C. M., Murphy, E. L., Sabino, E. C., Hisada, M., Galvão-Castro, B., Alcantara, L. C. J., Remondegui, C., Verdonck, K., et al. (2006) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892006000100007 · Cited by 111
Self-citationRecent advances in the treatment of adult T‐cell leukemia‐lymphomas
Utsunomiya, A., Choi, I., Chihara, D., & Seto, M. (2015) · Cancer Science · doi:10.1111/cas.12617 · Cited by 103
Einsiedel, L., Fernandes, L., Spelman, T., Steinfort, D., & Gotuzzo, E. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir766 · Cited by 99
Tanajura, D., Castro, N., Oliveira, P., Neto, A., Muniz, A., Carvalho, N. B., Orge, G., Santos, S., Glesby, M. J., & Carvalho, E. M. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ229 · Cited by 91
Afonso, P. V., Cassar, O., & Gessain, A. (2019) · Retrovirology · doi:10.1186/s12977-019-0504-z · Cited by 90
Phillips, A. A., Fields, P. A., Hermine, O., Ramos, J. C., Beltran, B. E., Pereira, J., Wandroo, F., Feldman, T., Taylor, G. P., Sawas, A., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.205096 · Cited by 70
Cellular Factors Involved in HTLV-1 Entry and Pathogenicit
Hoshino, H. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00222 · Cited by 58
“…periods of 40–60 years, approximately 5% of HTLV-1-infected individuals (6.6% of males and 2.1% of females) will develop ATL (Kajiyama et al., 1986; Murphy et al., 1989; Edlich www.frontiersin.org June 2012 | Volume 3 | Article 222 | 1 et al., 2000; Proietti et al., 2005; Sonoda et al., 2011).”
BackgroundInfluentialKannian, P., Yin, H., Doueiri, R., Lairmore, M. D., Fernandez, S., & Green, P. L. (2012) · Journal of Virology · doi:10.1128/jvi.06900-11 · Cited by 55
Integrase Inhibitors Effective against Human T-Cell Leukemia Virus Type 1
Seegulam, M. E., & Ratner, L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01413-10 · Cited by 54
Living Invisible: HTLV-1-Infected Persons and the Lack of Care in Public Health
Zihlmann, K. F., de Alvarenga, A. T., & Casseb, J. (2012) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001705 · Cited by 52
Panfil, A. R., Dissinger, N. J., Howard, C. M., Murphy, B. M., Landes, K., Fernandez, S. A., & Green, P. L. (2016) · Journal of Virology · doi:10.1128/jvi.03113-15 · Cited by 39
Structural basis of host protein hijacking in human T-cell leukemia virus integration
Bhatt, V., Shi, K., Salamango, D. J., Moeller, N. H., Pandey, K. K., Bera, S., Bohl, H. O., Kurniawan, F., Orellana, K., Zhang, W., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16963-6 · Cited by 39
Molecular targeting for treatment of human T-lymphotropic virus type 1 infection
Soltani, A., Hashemy, S. I., Zahedi Avval, F., Soleimani, A., Rafatpanah, H., Rezaee, S. A., Griffith, R., & Mashkani, B. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.139 · Cited by 31
Jinno-Oue, A., Tanaka, A., Shimizu, N., Mori, T., Sugiura, N., Kimata, K., Isomura, H., & Hoshino, H. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2012.0156 · Cited by 21
Fowler, F., & Einsiedel, L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.845594 · Cited by 9
Global HTLV-1/2 Burden and Associated Diseases
Williams, C. K. O. (2019) · Cancer and AIDS · doi:10.1007/978-3-319-99235-8_2 · Cited by 6
Bastos Ferreira, A. P., do Nascimento, A. D. F. S., & Sampaio Rocha-Filho, P. A. (2022) · Journal of NeuroVirology · doi:10.1007/s13365-021-01043-2 · Cited by 5
Metadata
- Authors
- Proietti, F. A., Carneiro-Proietti, A. B. F., Catalan-Soares, B. C., & Murphy, E. L.
- Venue
- Oncogene
- Published
- 2005-09-05
- Volume
- 24
- Issue
- 39
- Pages
- 6058-6068
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2078089821
- Cited by
- 1,008
- References
- 132
- FWCI
- 10.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.